发明名称 |
COMPOSITION COMPRISING BRANCHED MULTIPEPTIDE VACCINE AND VACCINE COMPRISING THE SAME |
摘要 |
Provided are a branched multi-peptide composition and a vaccine including the same. The branched multi-peptide vaccine according to the present invention is easy to be produced and utilized, thereby being easily applied to the treatment, and is capable of maintaining stable reaction in vivo, such that it is expected that the branched multi-peptide vaccine according to the present invention acts as an effective vaccine. Further, for the tumor antigen peptide, the present invention may select an antigen that is largely expressed in a malignant brain tumor. In addition, from now on, it is expected that tumor antigens having a large expression level may be analyzed depending on tumor characteristics of an individual patient, such that the branched multi-peptide vaccine according to the present invention may be utilized for producing personalized branched peptides and vaccines using the same. |
申请公布号 |
US2017037154(A1) |
申请公布日期 |
2017.02.09 |
申请号 |
US201514985660 |
申请日期 |
2015.12.31 |
申请人 |
INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY |
发明人 |
Jung Tae-Young;Kim Young-Hee |
分类号 |
C07K19/00;C07K14/47;C07K14/71;C07K7/06;C07K14/705 |
主分类号 |
C07K19/00 |
代理机构 |
|
代理人 |
|
主权项 |
1. A multi-peptide composition for cancer immunotherapy, represented by Chemical Formula I below: in Chemical Formula I, each of A, B and C is a subsequence residue of any one peptide selected from the group consisting of brain tumor antigens: CD99, BIRC5, ERBB2, WT-1 and PanDR epitope; Sp is a spacer that links the subsequence residue to lysine; and Lys is lysine. |
地址 |
Gwangju KR |